[Elsevier] Efficacy and safety of iclepertin for cognitive impairment associated with schizophrenia (CONNEX programme): results from three phase 3 randomised controlled trials

lsm003 Post time Half hour(s) ago | Show all posts |Read mode
This post will be closed automatically in 2026-11-02 19:50
Reward50points

PDF Link: https://www.thelancet.com/journals/lanpsy/article/PIIS2215-0366(25)00296-2/abstract

Article Info: Lancet Psychiatry. 2025 Dec;12(12):906-920. doi: 10.1016/S2215-0366(25)00296-2.

Reply

Use magic Donate Report

All Reply1 Show all posts
SIKANDAR2025 Post time 9 min. ago | Show all posts

Waiting for confirmation

If the PDF has not been accepted after 72 hours, the system will automatically adopt it.
Reply

Use magic Donate Report

Senior Member
  • post

  • reply

  • points

    1122


Daily Top Contributors

Return to the list